The World Market for Stents (Drug-Eluting and Bare Metal Product Markets in US, EU, Japan, India, China and ROW)

Oct 26, 2012
164 Pages - Pub ID: KLI4893601
Abstract Table of Contents Search Inside Report Related Reports

The coronary stents industry is a highly competitive one in which innovation occurs rapidly and the technology landscape evolves at a fast pace. As the global population is aging and has a longer life expectancy, the prevalence of coronary heart disease and co-morbid conditions such as hypertension, diabetes and obesity is projected to rise and stimulate the demand for coronary stents. Additionally, a growing acceptance of drug-eluting stents as a more effective treatment for coronary heart disease, along with increasing awareness about coronary stents among patients, is expected to boost procedural volumes. New technologies, such as bioresorbable scaffolds, and bifurcation and biodegradable polymers stents, are projected to enter major markets in the next years and increase the utilization of stents in interventional cardiology.

Despite the challenging environment, opportunities still exist in the global market for coronary stents, as there is still a high need for non-invasive therapies with enhanced safety and efficacy, and there are various niches of the market, such as bifurcation and complex lesions, that require more extensive treatment options. Additionally, the new bioresorbable stents have the potential to eliminate the negative issues of durable polymer stents, and are therefore expected to induce a significant shift in the treatment of coronary heart disease, encouraging also more patients to undergo stent implantation surgery.

This Report, The World Market for Stents (Drug Eluting and Bare Metal Product Markets in U.S., E.U., Japan, China, India and ROW), authored by medical device analyst Adriana Rusu,  provides a complete overview of cardiovascular disease, the role of stents in treatment, the success of bare metal and drug-eluting products, as well as market sizes and forecasts to 2017. Included in this reports coverage:
  • Market Size and Forecast -Cardiovascular Disease Statistics (Mortality, Morbidity, Cost by Country)
  • Regional Breakout of Bare Metal and Drug-Eluting Stent Markets (U.S., E.U., Japan, China, India, ROW)
  • Categorization of Drug-Eluting Stents by Polymer, Drug, Platform
  • Coronary Stents Using Biodegradable Polymers, Novel Coating and Direct Drug Application
  • Assessment of Bioresorbable Stents
  • Dedicated Bifurcation, Dedicated Small Vessel Stent Products
  • Major Competitors Market Share
  • Significant Trends in Market and Near and Long-Term Impact
  • Recent Mergers and Acquisitions
  • Key Company Profiles
The major markets of US, Europe, and Japan experienced significant challenges in recent years, including price declines, decreasing volumes of percutaneous coronary interventions, and lower penetration rates for drug-eluting stents resulted from cost constraints and reductions in healthcare budgets. Additionally, the intensified competition among manufacturers also contributed to the decline in average stent selling prices in these regions. Despite that, the market potential for coronary stents in these regions remains quite attractive, given the aging population and high longevity. However, the decreasing reimbursement rates and the intensifying competition for market share are expected to continue to lead to price declines and hamper significantly the market growth.

As part of its coverage of the stents industry, the following companies are profiled:
  • Abbott Laboratories
  • Biosensors International
  • Boston Scientific
  • Biotronik SE & Co.KG
  • CID Vascular
  • Elixir Medical Corporation
  • Medtronic
  • Meril Life Sciences Pvt. Ltd.
  • MicroPort Medical (Shanghai) Co., Ltd Minvasys
  • OrbusNeich
  • REVA Medical
  • Stentys S.A.
  • Terumo Corporation
The information for this report was gathered using both primary and secondary research including comprehensive research of secondary sources such as company literature, databases, investment reports, science, medical and business journals. Telephone interviews and email correspondence were the primary method of gathering information. For the purpose of this study Kalorama Information conducted interviews with key industry officials, consultants, and government personnel. These sources were the primary basis in gathering information specifically relating to revenue and market share data presented in this report. Specific interviews with pharmaceutical, biotechnology and contract research organizations included marketing directors, division managers, and product representatives.

Related Reports:

The Worldwide Market for In Vitro Diagnostic (IVD) Tests, 9th Edition
Aug 13, 2014 - KLI5309370 - $6,800.00

The World Market for Clinical Nutrition Products (Infant, Parenteral and Enteral Foods), 6th Edition
Jul 16, 2014 - KLI5296709 - $3,995.00

The World Market for Flow Cytometry in IVD Applications
Jun 16, 2014 - KLI5271977 - $1,995.00

The Global Market for Medical Devices, 5th Edition
May 28, 2014 - KLI5254463 - $2,500.00

Medical Device Markets in The Middle East
May 14, 2014 - KLI5241892 - $995.00

Vaccines 2014: World Market Analysis, Key Players, Trends, Pediatric and Adult Segments (Influenza, Cervical Cancer, Combinations, Hepatitis, Pneumococcal, MMR, Varicella, Poliovirus , HIB, Others)
Apr 21, 2014 - KLI5232511 - $3,995.00

EMR 2014: The Market for Electronic Medical Records
Apr 2, 2014 - KLI5225054 - $3,995.00

Surgical Procedure Volumes: Global Analysis (US, China, Japan, Brazil, UK, Germany, Italy, France, Mexico, Russia)
Feb 22, 2014 - KLI5205473 - $2,995.00

The Worldwide Market for Respiratory Devices (Inhalers, Nebulizers, Airways, Masks, Sleep Apnea, Oxygen Therapy, Ventilators Medical Humidifiers, Respiratory Measurement)
Jan 23, 2014 - KLI5192151 - $3,995.00

The World Market for Molecular Diagnostics Update (Microbiology, Histology, Blood Screening, Prenatal, Coagulation, Inherited Diseases, Tissue Typing, Cancer Markers, Pharmacodiagnostics, CTCs)
Jan 14, 2014 - KLI5181507 - $3,995.00

800.298.5603
Int'l: +1.240.747.3096
Questions?
Contact a research specialist >

Most Popular Research
World Market for Molecular Diagnostics, 5th. Edition (Infectious Disease, Oncology, Blood Screening, Pre-Natal and Other Areas)
The World Market for Cancer Diagnostics, 5th Edition: Precision and Personalized Testing Arrives
Kalorama Vaccine Market Research Report Bundle (Vaccines 2012, What's Next in Vaccines, Vaccine Production Markets)
White Paper: The Scourge of Cancer (Incidence by Country, Mechanisms, Growth Factors)
Vaccines 2012-16 World Market Analysis, Key Players, Trends, Pediatric and Adult Segments
The Market for Hospital-Acquired Infection Control (Sterilization, Disinfection, Testing and Treatment)
Privacy Policy    |    Terms and Conditions    |    Site Map    |    Return Policy    |    Press    |    Help FAQs
Home About Us My Account Personal Library Contact Us
Copyright © 2014 Kalorama Information. All Rights Reserved.
A division of Market Research Group, LLC
9/17/2014 - 40
Contact Us: 800.298.5603 (U.S.)
or +1.240.747.3096 (Int'l)
Hours: Monday - Thursday: 5:30am - 6:30pm EST
Fridays: 5:30am - 5:30pm EST